Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants

AIDS Research and Human Retroviruses

Volumn 14, Issue 4, 1998, Pages 329-337

  McCutchan, Francine E ^a,d   Sanders Buell, Eric ^a   Salminen, Mika O ^a,b   Carr, Jean K ^a   Sheppard, W Haynes ^c  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^d Henry M Jackson Found Res Lab   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; UNITED STATES; VIRUS TYPING;

EID: 0032032303     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.329     Document Type: Article

References (49)

1. Myers G, Korber B, Hahn BH, Jeang K-T, Mellors JW, McCutchan FE, Henderson LE, and Pavlakis GN (eds.): Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, 1995.
2. Burke DS and McCutchan FE: Global distribution of HIV-1 clades. In: AIDS: Etiology, Diagnosis, Treatment and Prevention (DeVita VT Jr, Hellman S, Rosenberg SA, Essex ME, Fauci AS, and Freeman JS, eds.), 4th Ed. Lippencott-Raven, Philadelphia, Pennsylvania, 1996.
3. Fast PE and Walker MC: Human trials of experimental AIDS vaccines. AIDS 1993;7(Suppl. 1):S147-S159.
4. Fischer RD and McNeil JG: Preparations for AIDS vaccine evaluations. Progress in international cohort development and evaluation. AIDS Res Hum Retroviruses 1994;10(Suppl. 2):S223-225.
5. Osmanov S, Heyward WL, and Esparza J: HIV-1 genetic variability: Implications for the development of HIV vaccines. Antibiot Chemother 1996;48:30-38.
6. McCutchan FE, Salminen MO, Carr JK, and Burke DS: HIV-1 genetic diversity. AIDS 1996;10(Suppl. 3):S13-S20.
7. Hu DJ, Dondero TJ, Rayfield MA, Gerogr JR, Schochetman G, Jaffe HW, Luo C-C, Kalish ML, Weniger BG, Pau C-P, Schable CA, and Curran JW: The emerging genetic diversity of HIV. JAMA 1996;275:210-216.
8. Expert Group of the Joint United National Programme on HIV/AIDS: Implications of HIV variability for transmission: Scientific and policy issues. AIDS 1997;11:1-15.
9. Meyerhans A, Cheynier R, Albert J, Seth M, Kwok S, Sninsky J, Morfeldt-Manson L, Asjo B, and Wain-Hobson S: Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989;58:901-910.
10. McNearney T, Hornickova Z, Markham R, Birdwell A, Arens M, Saah A, and Ratner L: Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc Natl Acad Sci USA 1992;89:10247-10251.
11. Pang S, Schlesinger Y, Daar ES, Moudgil T, Ho DD, and Chen ISY: Rapid generation of sequence variation during primary HIV-1 infection. AIDS 1992;6:453-460.
12. Koot M, van't Wout AB, Kootstra NA, de Goede Rey, Tersmette M, and Schuitemaker H: Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J Infect Dis 1996;173:349-354.
13. Wolinsky SM, Korber BTM, Neumann AU, Daniels M, Kuntsman KJ, Whetsell AJ, Furtado MR, Cao Y, Ho DD, Safrit JT, and Koup RA: Adaptive evolution of human immunodeficiency virus type-1 during the natural course of infection. Science 1996;272:537-542.
14. McDonald RA, Mayers DL, Chung RC-Y, Wagner K, Ratto-Kim S, Birx DL, and Michael NL: Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function. J Virol 1997;71:1871-1879.
15. Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, and Goudsmit J: HIV-1 V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies. Virology 1991;180:583-590.
16. Ball K, Holmes EC, Whitwell H, and Desselberger U: Genomic variation of immunodeficiency virus type 1 (HIV-1): Molecular analysis of HIV-1 in sequential blood samples and various organs obtained at autopsy. J Gen Virol 1994;75:67-79.
17. Overbaugh J, Anderson RJ, Ndinya-Achola JO, and Kreiss JK: Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood. AIDS Res Hum Retroviruses 1996;12:107-115.
18. Zhu T, Wang N, Carr A, Nam DS, Moor-Jankowski R, Cooper DA, and Ho DD: Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for compartmentalization and selection during sexual transmission. J Virol 1996;70:3098-3107.
19. Simmonds P, Zhang LQ, McOmish F, Balfe P, Ludlam CA, and Leigh Brown AJ: Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral population in vivo: Implications for models of HIV pathogenesis. J Virol 1991;65:6266-6276.
20. Michael NL, Chang G, Ehrenberg PK, Vahey MT, and Redfield RR: HIV-1 proviral genotypes from the peripheral blood mononuclear cells of an infected patient are differentially represented in expressed sequences. J AIDS 1993;6:1073-1085.
21. Scarlatti G, Leitner T, Halapi E, Wahlberg J, Marchisio P, Clerici-Schoeller MA, Wigzell H, Fenyö E-M, Albert J, Uhlen M, and Rossi P: Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci USA 1993;90:1721-1725.
22. Kusumi K, Conway B, Cunningham S, Berson A, Evans C, Iversen AKN, Colvin D, Gallo MV, Coutre S, Shaper EG, Faulkner DV, de Ronder A, Volkman S, Williams C, Hirsch MS, and Mullins JI: Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J Virol 1992; 66:875-885.
23. Lukashov VV and Goudsmit J: Increasing genotypic and phenotypic selection from the original genomic RNA populations of HIV-1 strains LAI and MN (NM) by peripheral blood mononuclear cell culture, B-cell-line propagation, and T-cell-line adaptation. AIDS 1995;9:1307-1311.
24. Moore JP and Ho DD: HIV-1 neutralization: The consequences of viral adaptation to growth on transformed T cells. AIDS 1995;9 (Suppl. A):S117-136.
25. Winkelstein W Jr, Lyman DM, Padian N, Grant R, Samuel M, Wiley JA, Anderson RE, Lang W, Riggs J, and Levy JA: Sexual practices and risk of infection by the human immunodeficiency virus. JAMA 1987;257:321-325.
26. Lang W, Anderson RE, Perkins H, Grant RM, Lyman D, Winkelstein W Jr, Royce R, and Levy JA: Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. JAMA 1987;257:326-330.
27. Winkelstein W Jr, Samuel M, Padian NS, Wiley JA, Lang W, Anderson RE, and Levy JA: The San Francisco Men's Health Study. III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-1986. Am J Public Health 1987;76:658-689.
28. Felsenstein J: PHYLIP - phylogenetic inference package (version 3.2). Cladistics 1989;5:164-166.
29. Saitou N and Nei M: The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4:406-425.
30. Felsenstein J: Confidence limits on phylogenies: An approach using the bootstrap. Evolution 1985;39:783-791.
31. Felsenstein J: Evolutionary trees from DNA sequences: A maximum likelihood approach. J Mol Evol 1981;17:368-376.
32. Sheppard HW, Lang W, Ascher MS, Vittinghoff E, and Winkelstein W: The characterization of non-progressors: Long-term HIV-1 infection with stable CD4T cell levels. AIDS 1993;7:1159-1166.
33. Hillis DM and Bull JJ: An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Syst Biol 1993;42:182-192.
34. Andeweg AC, Groenink M, Leeflang P, de Goede RE, Osterhaus AD, Tersmette M, and Bosch ML: Genetic and functional analysis of a set of HIV-1 envelope genes obtained from biological clones with varying syncytium-inducing capacities. AIDS Res Hum Retroviruses 1992;8:1803-1813.
35. Javaherian K, Langlois AJ, McDanal C, Ross KL, Echler LI, Jellis CL, Profy AT, Rusche JR, Bolognesi DP, and Matthews TJ: Principal neutralization domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci USA 1989; 86:6768-0772.
36. Kinney TE, Weber JN, McClure J, Clapham PR, Singhai MC, Shriver MK, and Weiss RA: Neutralising monoclonal antibodies to the AIDS virus. AIDS 1988;2:25-29.
37. LaRosa GJ, Davide JP, Weinhold K, Waterbury JA, Profy AT, Lewis JA, Langlois AJ, Dreesman GR, Boswell RN, Shadduck P, Holley CH, Karplus M, Bolognesi DP, Matthews TJ, Emini EA, and Putney SD: Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 1990;249: 932-935.
38. McCutchan FE, Hegerich P, Brennan T, Phanuphak P, Preecha P, Achasa T, Berman P, Fowler AK, and Burke DS: Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses 1992;8: 1887-1895.
39. Ou CY, Takebe Y, Luo CC, Kalish M, Auwanit W, Bandea C, de la Torre N, Gayle HD, Young NL, and Weniger BG: Wide distribution of two subtypes of HIV-1 in Thailand. AIDS Res Hum Retroviruses 1992;8:1471-1472.
40. Fouchier RAM, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Meidema F, and Schuitemaker H: Phenotype associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992; 66:3183-3187.
41. Kuiken C, de Jong J, Baan E, Keulen W, Tersmette M, and Goudsmit J: Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J Virol 1992; 66:4622-4627.
42. Gao F, Yue L, Hill SC, Robertson DL, Graves AH, Saag MS, Shaw GM, Sharp PM, and Hahn BH: HIV-1 sequence subtype D in the United States. AIDS Res Hum Retroviruses 1994;10:625-627.
43. Artenstein AW, Coppola J, Brown AE, Carr JK, Sanders-Buell E, Galbarini E, Mascola JR, VanCott TC, Schonbrood P, McCutchan FE, and Burke DS: Multiple introductions of HIV-1 subtype E into the Western hemisphere. Lancet 1995;346:1197-1198.
44. Brodine SK, Mascola JR, Weiss PJ, Ito SI, Porter KR, Artenstein AW, Garland FC, McCutchan FE, and Burke DS: Detection of diverse HIV-1 genetic subtypes in the USA. Lancet 1995;346: 1198-1199.
45. Irwin KL, Pau CP, Hu D, Lupo D, Schable CA, Olivo N, Minor P, Weber JT, Janssen R, Ernst J, and Rayfield M: Unusual HIV serotypes in a Bronx community with high HIV prevalence: A sentinel site monitoring HIV genetic diversity in North America. In: XIth International Conference on AIDS, Vancouver, British Columbia, July 1996. [Abstract We.C.345]
46. Loussert-Ajaka I, Deschamps D, Simon F, Brun-Vezinet F, Ekwalanga M, and Saragosti S: Genetic diversity and HIV detection by polymerase chain reaction. Lancet 1995;346:912-913.
47. Dunne AL and Crowe SM: Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma. AIDS 1997;11:126-127.
48. Brown AE, Robb M, and McCutchan FE: Polymerase chain reaction for diagnosis of HIV infection. Ann Intern Med 1997;126:739.
49. Michael N, Robb M, Birx D, Wang J, Dreyer K, McDonough K, Christopherson C, Lu SD, Kwok S, and Herman S: Performance of the AMPLICOR HIV-1 MONITOR™ test and a modified HIV-1 MONITOR test on HIV-1 subtypes A to F. In: 4th Conference on Retroviruses and Opportunistic Infections, Washington DC, January, 1997. [Abstract 279]